Five years later : re-examining the financial burden of boosting with NorvirMARQUEZ, Carina; GUGLIELMO, B. Joseph; KLAUSNER, Jeffrey D et al.AIDS (London). 2008, Vol 22, Num 17, pp 2402-2404, issn 0269-9370, 3 p.Article

Midwife attitudes: An important determinant of maternal postpartum pertussis booster vaccinationCHENOA COOPER ROBBINS, Spring; LEASK, Julie; HELEN HAYLES, Elizabeth et al.Vaccine. 2011, Vol 29, Num 34, pp 5591-5594, issn 0264-410X, 4 p.Article

Boosting Salt Resistance of Short Antimicrobial PeptidesCHU, Hung-Lun; YU, Hui-Yuan; YIP, Bak-Sau et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 8, pp 4050-4052, issn 0066-4804, 3 p.Article

Boosting biofuel crops could threaten food securityBODDIGER, David.Lancet (British edition). 2007, Vol 370, Num 9591, pp 923-924, issn 0140-6736, 2 p.Article

Postpartum prevention of pertussis in a French maternity hospital: Impact on general practitionersLEBOUCHER, Bertrand; ABBOU, Fatma; GASCOIN, Géraldine et al.Vaccine. 2013, Vol 31, Num 44, pp 5118-5126, issn 0264-410X, 9 p.Article

Pertussis: An under-diagnosed disease with high morbidity in Singapore childrenGON, Anne; CHIA YIN CHONG; TEE, Nancy et al.Vaccine. 2011, Vol 29, Num 13, pp 2503-2507, issn 0264-410X, 5 p.Article

EFFECT OF A PREPREGNANCY PERTUSSIS BOOSTER DOSE ON MATERNAL ANTIBODY TITERS IN YOUNG INFANTSLEURIDAN, Elke; HENS, Niel; PEETERS, Natasja et al.The Pediatric infectious disease journal. 2011, Vol 30, Num 7, pp 608-610, issn 0891-3668, 3 p.Article

Antibody persistence of two pentavalent DTwP―HB―Hib vaccines to the age of 15―18 months, and response to the booster dose of quadrivalent DTwP―Hib vaccineSHARMA, Hitt; YADAV, Sangeeta; SHEWALE, Sunil et al.Vaccine. 2013, Vol 31, Num 3, pp 444-447, issn 0264-410X, 4 p.Article

Short-term booster effect of diphtheria toxoid in initially long-term protected individualsDANILOVA, Elena; SHIRYAYEV, Alexey; SKOGEN, Vegard et al.Vaccine. 2005, Vol 23, Num 12, pp 1446-1450, issn 0264-410X, 5 p.Article

Copper-Boosting Compounds: a Novel Concept for Antimycobacterial Drug DiscoverySPEER, Alexander; SHRESTHA, Tej B; BOSSMANN, Stefan H et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 2, pp 1089-1091, issn 0066-4804, 3 p.Article

High tetanus and diphtheria antitoxin concentrations in Finnish adults―Time for new booster recommendations?OLANDER, R.-M; AURANEN, K; HARKANEN, T et al.Vaccine. 2009, Vol 27, Num 39, pp 5295-5298, issn 0264-410X, 4 p.Article

Waning immunity and booster responses in nursing and medical technology students who had received plasma-derived or recombinant hepatitis B vaccine during infancyLIN, Ching-Chiang; YANG, Chun-Yuh; SHIH, Ching-Tang et al.American journal of infection control. 2011, Vol 39, Num 5, pp 408-414, issn 0196-6553, 7 p.Article

Designer boostersDENNIS, Tony; HOLTON, Ron.Hydrocarbon engineering. 2004, Vol 9, Num 8, pp 53-56, issn 1468-9340, 3 p.Article

Two-step tuberculin skin test and booster phenomenon prevalence among Brazilian medical studentsTEIXEIRA, E. G; KRITSKI, A; RUFFINO-NETTO, A et al.The International journal of tuberculosis and lung disease. 2008, Vol 12, Num 12, pp 1407-1413, issn 1027-3719, 7 p.Article

Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaignLADHANI, S; SLACK, M. P; HEYS, M et al.Archives of disease in childhood. 2008, Vol 93, Num 8, pp 665-669, issn 0003-9888, 5 p.Article

Working characteristics of two kinds of air-driven boostersYAN SHI; MAOLIN CAI.Energy conversion and management. 2011, Vol 52, Num 12, pp 3399-3407, issn 0196-8904, 9 p.Article

Persistence of Antibody Response Following a Booster Dose of Hib-MenC-TT Glycoconjugate Vaccine to Five Years: A Follow-up StudyKHATAMI, Ameneh; SNAPE, Matthew D; WYSOCKI, Jacek et al.The Pediatric infectious disease journal. 2012, Vol 31, Num 10, pp 1069-1073, issn 0891-3668, 5 p.Article

Pertussis antitoxin decay after vaccination with DTPa response to a first booster dose 31/2-61/2 years after the third vaccine doseHALLANDER, Hans O; GUSTAFSSON, Lennart; LJUNGMAN, Margaretha et al.Vaccine. 2005, Vol 23, Num 46-47, pp 5359-5364, issn 0264-410X, 6 p.Article

Antibody Persistence After Primary and Booster Doses of a Quadrivalent Meningococcal Conjugate Vaccine in AdolescentsBAXTER, Roger; REISINGER, Keith; BLOCK, Stanley L et al.The Pediatric infectious disease journal. 2014, Vol 33, Num 11, pp 1169-1176, issn 0891-3668, 8 p.Article

Immunogenicity and booster efficacy of pre-exposure rabies vaccinationSTRADY, C; ANDREOLETTI, L; BAUMARD, S et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 2009, Vol 103, Num 11, pp 1159-1164, issn 0035-9203, 6 p.Article

A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adultsBOOY, Robert; VAN DER MEEREN, Olivier; NG, Su-Peing et al.Vaccine. 2010, Vol 29, Num 1, pp 45-50, issn 0264-410X, 6 p.Article

Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of lifeKNUF, M; HABERMEHL, P; FABER, J et al.Vaccine. 2006, Vol 24, Num 27-28, pp 5627-5636, issn 0264-410X, 10 p.Article

Determination of Immune Memory to Hepatitis B Vaccination Through Early Booster Response in College StudentsJAN, Chyi-Feng; HUANG, Kuo-Chin; CHIEN, Yin-Chu et al.Hepatology (Baltimore, Md.). 2010, Vol 51, Num 5, pp 1547-1554, issn 0270-9139, 8 p.Article

Effects of vehicle seat and belt geometry on belt fit for children with and without belt positioning booster seatsREED, Matthew P; EBERT-HAMILTON, Sheila M; KLINICH, Kathleen D et al.Accident analysis and prevention. 2013, Vol 50, pp 512-522, issn 0001-4575, 11 p.Article

Immunogenicity and safety of diphtheria―tetanus vaccine in pre-adolescent and adolescent South KoreansSOO YOUNG LEE; GA YOUNG KWAK; CHAN HEE NAM et al.Vaccine. 2009, Vol 27, Num 24, pp 3209-3212, issn 0264-410X, 4 p.Article